Skip to main content

An unusual case of Cardiobacterium valvarum causing aortic endograft infection and osteomyelitis



HACEK (Haemophilus spp., Aggregatibacter spp., Cardiobacterium spp., Eikenella corrodens, and Kingella spp.) group organisms are responsible for 0.8% to 6% of all infective endocarditis cases, with Cardiobacterium spp. being the third most commonly implicated HACEK microorganism. Within this genus is Cardiobacterium valvarum (C. valvarum), a novel organism described in 2004. To date, only 15 cases of C. valvarum infection have been reported in the English-language literature, and have primarily been cases of infective endocarditis in patients with valvular disease. C. valvarum has not been reported to cause infections spreading to the surrounding bone.

Case presentation

We present a case of a 57-year-old man with a history of aortic dissection followed by aortic endograft replacement who presented with back pain. He was found to have radiographic evidence of an infected aortic endograft, along with vertebral osteomyelitis, discitis, and epidural phlegmon. Blood cultures identified C. valvarum as the causative organism. The patient was treated with ceftriaxone and surgical intervention was deferred due to the patient’s complex anatomy. His course was complicated by septic cerebral emboli resulting in cerebrovascular accident.


This case report highlights C. valvarum, a rare and emerging HACEK group microorganism that warrants consideration in high-risk patients with evidence of subacute infection and disseminated disease. While C. valvarum classically presents as infective endocarditis, extra-cardiac manifestations have also been described. As demonstrated in this case, endograft involvement and osteomyelitis may occur in rare circumstances.


Cardiobacterium spp. are fastidious, pleomorphic Gram-negative bacilli that belong to the HACEK (Haemophilus spp., Aggregatibacter spp., Cardiobacterium spp., Eikenella corrodens, and Kingella spp.) group of microorganisms, a group of bacteria that share similar microbiological and clinical characteristics. Species within this group have been reported to be responsible for 0.8–6.0% of all infective endocarditis cases [1]. Although an uncommon cause of endocarditis overall, Cardiobacterium spp. are the third most common HACEK microorganism implicated in HACEK endocarditis [1]. Few reports of extra-cardiac Cardiobacterium spp. infection have been described [2, 3], and there are no known reports of the C. valvarum species being implicated in osteomyelitis.

Herein, we report a case of C. valvarum aortic endograft infection, which was further complicated by vertebral discitis, epidural phlegmon, septic cerebral emboli, and the first known case of C. valvarum osteomyelitis. A review of the English-language literature follows the case presentation.

Case presentation

In June 2020, a 57-year-old man was directly admitted to the hospital for radiologic evidence of vertebral osteomyelitis, discitis, and epidural phlegmon. He had a history of hypertension, hyperlipidemia, prediabetes, chronic kidney disease, and an acute Stanford Type A and Type B aortic dissection. His Type A aortic dissection (defined as involvement of the ascending aorta) had led to an emergent resection and replacement of the ascending aorta and proximal arch with a Dacron endograft nine years prior to his current presentation. Subsequent progression of an associated aortic arch aneurysm required surgical revision with a Dacron endograft exchange five years after initial surgical repair. His Type B dissection (defined as being limited to the aorta distal to the left subclavian artery without involvement of the ascending aorta) extended from the proximal aortic arch to the aortic bifurcation and remained untreated, though partially thrombosed. He had no other recent surgical instrumentation and his last dental procedure was ~ 24 months prior to his current presentation. Medications included amlodipine, aspirin, atorvastatin, carvedilol, ezetimibe, and lisinopril. He used alcohol socially and had never used tobacco or illicit drugs.

The patient had been well until ~ 6 weeks prior when isolated lower back pain developed. At that time, an outpatient non-contrast-enhanced magnetic resonance imaging (MRI) of the lumbar spine demonstrated significant edema within the vertebral bodies adjacent to the L4–L5 intervertebral disc space. Given his absence of systemic symptoms, short-term follow-up was advised. Two weeks later, a repeat contrast-enhanced MRI of the lumbar spine demonstrated progressive T2 hyperintensity at the L4–L5 intervertebral disc space and adjacent endplates with near complete involvement of the L3 and L4 vertebral bodies, highly suggestive of vertebral osteomyelitis and discitis (Fig. 1a). In addition, there was a 6 mm thick anterior epidural thickening and enhancement suggestive of epidural phlegmon that extended to L3 superiorly, S1 inferiorly, and the posterior wall of the known abdominal aortic aneurysm anteriorly (Fig. 1b). He was admitted for further workup and management.

Fig. 1

Magnetic resonance imaging (MRI) of the lumbar spine demonstrating discitis and vertebral osteomyelitis. T1 post-contrast sagittal MRI demonstrating enhancement at the L3–4 intervertebral disc space with erosions in the adjacent endplates (arrow)

On admission, a temperature of 37.2 °C, heart rate of 74 beats per min, blood pressure of 129/67 mm Hg, and body-mass index of 32.7 were observed. On examination, there were multiple dental amalgam fillings and a 3/6 systolic murmur best appreciated in the aortic region, which was stable from prior. The remainder of the examination, including a focused neurologic, musculoskeletal, and dermatologic assessment, was normal. Basic laboratory tests were remarkable for anemia of inflammation, a C-reactive protein of 1.6 mg/dL (reference range, 0.0–0.5 mg/dL), an erythrocyte sedimentation rate of 53 mm/h (reference range, 3–10 mm/h), and the absence of leukocytosis. Aerobic and anaerobic peripheral blood cultures were obtained, and empiric vancomycin 1 g intravenously every 12 h and cefepime 2 g intravenously every 12 h were administered due to the proximity of the epidural phlegmon to the posterior wall of the known abdominal aortic aneurysm.

A series of diagnostic tests were subsequently performed. Computed tomography (CT) angiography of the thoracic aorta showed a soft tissue density located on the ascending aortic endograft, favored to be infectious in etiology. Transesophageal echocardiogram showed previously noted strand-like mobile echodensities on the right coronary cusp of the aortic valve, favored to represent Lambl’s excrescences (defined as thin, fibrinous structures at the lines of valve closure and postulated to be related to shear forces to the endothelium) [4]. There were no other valvular abnormalities or signs of valvular insufficiency. Contrast-enhanced CT of the face showed no evidence of dental disease. Fluoroscopy-guided bone biopsy of the L4 vertebral body obtained on day 3 of admission showed changes suggestive of resolving osteomyelitis. On day 4 of admission, 2 of 2 bottles on both sets of initial peripheral blood cultures signaled positive at 96 h of incubation. Macroscopically, colonies were described as irregular, small, round, and opaque in color. Nevertheless, due to poor growth secondary to the fastidious nature of the organism, susceptibilities were unable to be performed. Bipolar-staining pleomorphic Gram-negative rod-shaped bacilli were seen on microscopy (Fig. 2). 16S ribosomal RNA sequencing analysis subsequently identified C. valvarum (see Appendix 1 for further information regarding methods). Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry for further identification was not performed. Aerobic and anaerobic vertebral biopsy cultures remained negative and 16S ribosomal RNA sequencing was unfortunately not performed on these specimens. Though not definitively documented in the bone, C. valvarum identified in the blood was presumed to be the cause of the focal lesion as well.

Fig. 2

Gram staining. Microscopic morphology in gram staining of blood culture after 96 h of aerobic incubation at 37 °C demonstrating bipolar-staining gram-negative bacilli. 16S ribosomal RNA (rRNA) sequencing subsequently identified the organism as Cardiobacterium valvarum

Antimicrobial therapy was changed to ceftriaxone 2 g intravenously daily and prescribed for a 6-week course. Given radiologic evidence of a possible aortic endograft nidus, a vascular surgery evaluation was obtained. Surgical intervention was ultimately deferred due to the high likelihood of extensive endograft involvement and the technical difficulty posed by the patient’s complex surgical history. The patient was discharged home on day 9 of admission with multidisciplinary follow-up and outpatient antimicrobial therapy.

Twenty days later, the patient was readmitted for acute headache and blurry vision in the left eye. MRI of the brain at that time showed a moderate-sized acute and subacute right posterior cerebral artery (PCA) territory infarct of the right occipital and posterior temporal lobes with a small focus of associated hemorrhagic transformation. Magnetic resonance angiography of the brain subsequently showed poor flow-related signal of the right PCA P3/P4 segment with a paucity of vessels in the right occipital lobe suspicious for occlusion. Monitoring of the bilateral PCAs with a 2-MHz transcranial doppler ultrasound showed nine microembolic signals within the right PCA, suspicious for septic emboli. No neurosurgical intervention was pursued, initial antithrombotic therapy was held, and repeat peripheral blood cultures were negative. Positron emission tomography–computed tomography (PET/CT) was then obtained to better characterize the aortic endograft, which showed hypermetabolic soft tissue along the right lateral and anterior aspect of the ascending aortic graft, once again suspicious for endograft infection (Fig. 3). Surgical intervention was again deferred, and the patient was discharged home on hospital day 7. He was continued on ceftriaxone 2 g intravenously daily with the addition of clopidogrel 75 mg daily and levetiracetam 1 g twice daily. He remains well in multidisciplinary outpatient follow-up with marked improvement in his back pain and no further complication. He will remain on lifelong suppressive antimicrobial therapy following his initial treatment course.

Fig. 3

Positron emission tomography–computed tomography (PET/CT) of the chest. Hypermetabolic soft tissue (arrows) along the right lateral and anterior aspect of the ascending aortic endograft with a maximum standardized uptake value of 9.4, suspicious for aortic endograft infection


The Cardiobacterium genus was first described in 1964 when its major and prior sole species, C. hominis, was recognized as a distinct microorganism by Slotnick and Dougherty [5]. C. hominis itself is a low-virulence, commensal and facultative Gram-negative bacillus that typically manifests in patients with subacute endocarditis. Historically, its microbiologic detection has been challenging due to its fastidious nature and slow-growth on traditional media.

In 2004, a novel Cardiobacterium species designated C. valvarum was isolated from the blood of a 37-year-old man with subacute endocarditis of a congenital bicuspid aortic valve and sudden rupture of a cerebral aneurysm [6]. In comparison to the major C. hominis species, C. valvarum grows more slowly, is non-hemolytic on sheep blood agar, and does not utilize sucrose, maltose, or mannitol on traditional media [6]. Since its initial recognition, there have been 15 total cases of C. valvarum infection reported in the English-language literature, all of which have utilized 16S ribosomal RNA sequencing as a means of detection [6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23]. Table 1 provides an overview of these cases. In the overwhelming majority, clinical presentations are insidious and without apparent signs of a systemic inflammatory response, such as pyrexia or chills [6, 7, 12,13,14,15,16]. Factors that appear to predispose patients to infection with C. valvarum include recent dental instrumentation [6, 10, 15, 16], poor dentition [9, 15, 18], and congenital cardiac disease [6, 8,9,10, 12, 13, 15,16,17, 19]. Importantly, the presence of a congenital bicuspid aortic valve appears to be strongly associated with C. valvarum pathogenicity [6, 8, 9, 13, 16, 19]. Common imaging findings in infected hosts typically include large (> 1 cm) valvular vegetations on echocardiography [6,7,8,9, 12, 16, 18, 20], and, in settings where acute neurologic dysfunction is evident, septic cerebral emboli resulting in cerebrovascular accident [6,7,8, 12,13,14, 18].

Table 1 Existing case reports documenting infection by Cardiobacterium valvarum

In the present case, C. valvarum bacteremia was suspected to have caused an endograft infection, later spreading to the bone. The presumed source of C. valvarum was the oral cavity given that the patient had undergone at least one dental procedure in the interim between his aortic arch surgical revision and the onset of lower back pain. While it is unclear if the patient was ever prescribed prophylactic antibiotic therapy prior to any known dental procedure, one possibility is that transient bacteremia resulting from one of these procedures seeded the aortic Dacron endograft. Transient bacteremia may also have resulted from manipulation associated with toothbrushing. The endograft may have then served as a nidus for recurrent episodes of transient bacteremia, leading to lumbar spine infection with subsequent development of osteomyelitis and contiguous spread into the epidural and intervertebral disc spaces. It should be noted that a single report of C. valvarum aortic endograft infection confirmed by 16S ribosomal RNA sequence analysis has been previously described in a 53-year-old man with total aortic arch replacement and severe aortic regurgitation in Japan [14]. Likewise, a Cardiobacterium spp (C. hominis) causing vertebral osteomyelitis, discitis, and epidural abscess has also been described [21]. To our knowledge, the present case describes the first known case of C. valvarum both affecting an aortic endograft and resulting in osteomyelitis. It should be noted that, in our case, vertebral bone biopsy cultures did not grow any organisms, although the C. valvarum identified in the blood was presumed to be the cause of the osteomyelitis as well.

In any patient with confirmed Cardiobacterium spp. infection, careful evaluation for the presence of infective endocarditis is mandatory given the high likelihood of cardiac involvement. In contrast to the majority of cases shown in Table 1 that met modified Duke criteria for “Definite” infective endocarditis, the present case was designated as “Possible” infective endocarditis by only meeting one major clinical criterion (blood cultures with a typical infective endocarditis microorganism) and two minor clinical criteria (predisposing cardiac condition and vascular phenomena) [22]. Notably, there was no echocardiographic evidence of endocardial or valvular involvement on both transthoracic and transesophageal studies. While mobile strand-like echodensities were noted on aortic valve imaging, these were favored to represent Lambl’s excrescences [4] and had been noted on previous echocardiographic examinations that predated his aortic dissection. Therefore, though rare, it appears that C. valvarum has the potential for pathogenicity in the absence of cardiac involvement.

Antimicrobial therapy is the cornerstone of management for all C. valvarum infections, and surgical consultation is warranted in cases with an obvious radiologic and/or echocardiographic nidus. The standard antimicrobial therapy for HACEK group microorganisms in existing guidelines is ceftriaxone 2 g intravenously daily for 4 weeks [23], and most reports have successfully utilized this regimen [10, 13, 15,16,17, 19]. The empiric choice of antimicrobial therapy has varied in published cases (Table 1), which is likely explained by local patterns of resistance, country-specific practices, and the presence or absence of embolic disease. Given the rarity of extra-cardiac manifestations, no guidelines dictate treatment of C. valvarum infection in this setting. Overall, C. valvarum appears to be susceptible to most antibiotics, with low minimum inhibitory concentrations to penicillins, cephalosporins, fluoroquinolones, and aminoglycosides [6,7,8, 10, 12].


We report a case of C. valvarum-associated aortic endograft infection, which was further complicated by vertebral discitis, epidural phlegmon, septic cerebral emboli, and the first known case of C. valvarum osteomyelitis. C. valvarum is a rare and emerging HACEK group microorganism that warrants consideration in high-risk patients with evidence of subacute infection and disseminated disease. Most cases have successfully been treated with a third-generation cephalosporin. Source control may not be feasible in cases with complex anatomy and disseminated spread.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.



Computed tomography


Haemophilus Spp., Aggregatibacter spp., Cardiobacterium spp., Eikenella corrodens, and Kingella spp.


Magnetic resonance imaging


Posterior cerebral artery


  1. 1.

    Chambers ST, Murdoch D, Morris A, et al. HACEK infective endocarditis: characteristics and outcomes from a large, Multi-National Cohort. PLoS ONE. 2013;8:e63181.

    CAS  Article  Google Scholar 

  2. 2.

    Rechtman DJ, Nadler JP. Abdominal abscess due to Cardiobacterium hominis and Clostridium bifermentans. Rev Infect Dis. 1991;13:418–9.

    CAS  Article  Google Scholar 

  3. 3.

    Bhan I, Chen EJ, Hazari B. Isolation of Cardiobacterium hominis from the peritoneal fluid of a patient on continuous ambulatory peritoneal dialysis. Scand J Infect Dis. 2006;38:301–3.

    Article  Google Scholar 

  4. 4.

    Roldan CA, Shively BK, Crawford MH. Valve excrescences: prevalence, evolution and risk for cardioembolism. J Am Coll Cardiol. 1997;30:1308–14.

    CAS  Article  Google Scholar 

  5. 5.

    Slotnick IJ, Dougherty M. Further characterization of an unclassified group of bacteria causing endocarditis in man: Cardiobacterium hominis gen. et sp. n. Antonie Van Leeuwenhoek. 1964;30:261–72.

    CAS  Article  Google Scholar 

  6. 6.

    Han XY, Meltzer MC, Woods JT, et al. Endocarditis with ruptured cerebral aneurysm caused by Cardiobacterium valvarum sp. nov. J Clin Microbiol. 2004;42:1590–5.

    Article  Google Scholar 

  7. 7.

    Abraham R, Irwin RB, Kannappan D, et al. Cerebral vasculitis and Cardiobacterium valvarum endocarditis. J Med Microbiol. 2012;61:1625–30.

    CAS  Article  Google Scholar 

  8. 8.

    Bonavent TB, Nielsen XC, Kristensen KS, et al. Cardiobacterium hominis and Cardiobacterium valvarum: two case stories with infective episodes in pacemaker treated patients. Open Microbiol J. 2016;10:183–7.

    Article  Google Scholar 

  9. 9.

    Bothelo E, Gouriet F, Fournier PE, et al. Endocarditis caused by Cardiobacterium valvarum. J Clin Microbiol. 2006;44:657–8.

    Article  Google Scholar 

  10. 10.

    Chen M, Kemp M, Bruun NE, et al. Cardiobacterium valvarum infective endocarditis and phenotypic/molecular characterization of 11 Cardiobacterium species strains. J Med Microbiol. 2011;60:522–8.

    Article  Google Scholar 

  11. 11.

    Choudhury S, Isais FS, Lee CC. Nonsurgical management of mitral valve endocarditis due to Cardiobacterium valvarum in a patient with a ventricular septal defect. J Clin Microbiol. 2013;51:1996–7.

    Article  Google Scholar 

  12. 12.

    Geissdörfer W, Tandler R, Schlundt C, et al. Fatal bioprosthetic aortic valve endocarditis due to Cardiobacterium valvarum. J Clin Microbiol. 2007;45:2324–6.

    Article  Google Scholar 

  13. 13.

    Gonzalez J, Woc-Colburn L, Schreckenberger P, et al. Bicuspid aortic valve endocarditis due to Cardiobacterium valvarum: case report and review of literature. Infect Dis Clin Pract (Baltim Md). 2007;15:364–7.

    Article  Google Scholar 

  14. 14.

    Hagiya H, Kokeguchi S, Ogawa H, et al. Aortic vascular graft infection caused by Cardiobacterium valvarum: a case report. J Infect Chemother. 2014;20:804–9.

    Article  Google Scholar 

  15. 15.

    Hoffman MJ, Macrie BD, Taiwo BO, et al. Prosthetic valve/conduit infection caused by Cardiobacterium valvarum. Infection. 2010;38:245–6.

    CAS  Article  Google Scholar 

  16. 16.

    Hoover SE, Fisher SH, Shaffer R, et al. Endocarditis due to a novel Cardiobacterium species. Ann Intern Med. 2005;142:229–30.

    Article  Google Scholar 

  17. 17.

    Irabien Á, Gil-Jaurena JM, Pita A, et al. Double-barrel endocarditis. J Card Surg. 2019;34:1100–2.

    Article  Google Scholar 

  18. 18.

    Ni L, Xie X, Ouyang N, et al. A case of Cardiobacterium valvarum endocarditis with cerebral hemorrhage after MVR, TVP and vegetation removal operation. Ann Clin Microbiol Antimicrob. 2018;17:11.

    Article  Google Scholar 

  19. 19.

    Pusch T, Fisher MA, Gander RM. Cardiobacterium valvarum, an emerging new HACEK organism, as the causative agent of infective endocarditis: case report and review of the literature. Clin Microbiol Newsl. 2015;37:127–32.

    Article  Google Scholar 

  20. 20.

    Vaněrková M, Žaloudíková B, Němcová E, et al. Detection of Cardiobacterium valvarum in a patient with aortic valve infective endocarditis by broad-range PCR. J Med Microbiol. 2010;59:231–4.

    Article  Google Scholar 

  21. 21.

    Yadava SK, Eranki A. Vertebral osteomyelitis, discitis, and epidural abscess: a rare complication of Cardiobacterium Endocarditis. J Investig Med High Impact Case Rep. 2018;6:2324709618807504.

    PubMed  PubMed Central  Google Scholar 

  22. 22.

    Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.

    CAS  Article  Google Scholar 

  23. 23.

    Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30:2369–413.

    Article  Google Scholar 

Download references


The authors would like to thank Drs. Ramez Abdalla and Patrick Hackler for their assistance with the radiographic images.


This work was not supported by any external funding.

Author information




EGH, IN, BBY, and KMK all participated in the workup and treatment of the patient. EGH participated in the collection of data and the initial writing of the manuscript. IN and BBY performed a literature search and contributed to writing the manuscript. KMK and IN obtained pathology and radiology images. KMK reviewed the article and suggested final changes before submission. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Imran Nizamuddin.

Ethics declarations

Ethics approval and consent to participate

Not applicable (IRB approval is not required at Northwestern University) for case reports of a single patient. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. The patient has consented to the submission of the case report to the journal.

Consent for publication

Written and verbal consent was obtained from the patient prior to manuscript submission.

Competing interests

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this paper.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Appendix 1

Appendix 1

One colony of organism was suspended in 50 μl of water and boiled at 100 °C for 10 min. The cell lysate was then centrifuged at 12,000 × g for 5 min to precipitate cellular debris, and the supernatant was transferred to a new sterile tube. Polymerase chain reaction amplification and sequencing of the 860 bp fragment of 16S rRNA gene was performed with the primers 5′-GAGTTTGATYMTGGCTCAGRRYGAACGCT-3′ and 5′-GACTACCAGGGTATCTAATCC-3′, corresponding to E. coli 16S rRNA positions 9–30 and 804–783, respectively. Identification of organism was determined by matching with sequences from GenBank with the top score.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hauser, E.G., Nizamuddin, I., Yarusi, B.B. et al. An unusual case of Cardiobacterium valvarum causing aortic endograft infection and osteomyelitis. Ann Clin Microbiol Antimicrob 20, 14 (2021).

Download citation


  • Cardiobacterium valvarum
  • Infective endocarditis
  • Aortic endograft infection
  • HACEK organisms